Testing Salovum for glioblastoma: oxygen and pressure
Part of Cancer clinical trials.
This trial tests if Salovum, a special egg yolk product, can improve oxygen levels and reduce pressure and inflammation in the brain for people with a suspected glioblastoma. It involves a biopsy before treatment starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected glioblastoma (a type of brain tumor)
- You are between 18 and 75 years old
- You are scheduled for a diagnostic brain biopsy
- You can and want to give informed consent (agree to join after learning the details)
- You do not have a known allergy to egg yolk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an “antisecretory factor” treatment in people with grade 4 glioblastoma (or astrocytoma). It aims to see whether it can improve outcomes when used alongside planned cancer treatments after surgery.
This trial tests whether two special food products (Salovum and SPC Flakes) can help reduce brain swelling caused by tumors. If you have a brain tumor with swelling and are already on steroids, you may be able to join.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This trial tests a new immunotherapy called PERCELLVAC-Sur that targets a protein (Survivin) found in glioblastoma tumors. It is given after standard radiation and chemotherapy, and the goal is to see if it helps the immune system fight the cancer more effectively.
This trial tests a special MRI technique to help surgeons remove more of a glioblastoma brain tumor during surgery. The goal is to see if this approach helps people live longer.
This trial tests a new drug combination for people with newly diagnosed glioblastoma, a type of brain cancer. It adds an immunotherapy drug (adebrelimab) to standard chemotherapy, and some participants also receive hyperbaric oxygen therapy, which may help the treatment work better.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.